+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 185 Pages
  • December 2023
  • Region: Global
  • GlobalData
  • ID: 5680708
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Medical Devices sector report, “Point of Care (POC) Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Point of Care (POC) Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

POC analyzers are small-size, handheld or bench-top analyzers. These analyzers are small scale analyzers, often used in small laboratories and physician labs, where the workload and daily sample inflow is less. They often use disposable test cartridges and can provide faster results. One unit refers to one Point of Care (POC) analyzer.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Point of Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point of Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point of Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Point of Care (POC) Analyzers Overview
3 Products under Development
3.1 Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
3.2 Point of Care (POC) Analyzers - Pipeline Products by Segment
3.3 Point of Care (POC) Analyzers - Pipeline Products by Territory
3.4 Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
3.5 Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
3.6 Point of Care (POC) Analyzers - Ongoing Clinical Trials
4 Point of Care (POC) Analyzers - Pipeline Products under Development by Companies
4.1 Point of Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
4.2 Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
5 Point of Care (POC) Analyzers Companies and Product Overview6 Point of Care (POC) Analyzers- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
  • Point of Care (POC) Analyzers - Pipeline Products by Segment
  • Point of Care (POC) Analyzers - Pipeline Products by Territory
  • Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
  • Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
  • Point of Care (POC) Analyzers - Ongoing Clinical Trials
  • Point of Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
  • Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Point of Care (POC) Analyzers - Pipeline Products by Stage of Development
  • Point of Care (POC) Analyzers - Pipeline Products by Segment
  • Point of Care (POC) Analyzers - Pipeline Products by Territory
  • Point of Care (POC) Analyzers - Pipeline Products by Regulatory Path
  • Point of Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
  • Point of Care (POC) Analyzers - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Access Bio Inc
  • Acousort AB
  • Acrongenomics Inc (Inactive)
  • AgPlus Diagnostics LTD
  • Akonni Biosystems Inc
  • Alere Inc
  • All Medicus Co Ltd
  • Analytical Diagnostic Solutions Inc
  • ApoCell Inc
  • Aptatek BioSciences Inc
  • AquaBioChip, LLC
  • Atonomics A/S (Inactive)
  • Aviv Biomedical, Inc.
  • Besst Test
  • Binghamton University
  • Bio-AMD Inc
  • BioMedomics Inc
  • Biopico Systems Inc
  • Biosensia Ltd
  • Boston University
  • BreviTest Technologies LLC
  • Brigham and Women's Hospital
  • Canon USA Inc
  • Center for Innovation in Point-of-Care Technologies for HIV/AIDS
  • ChipCare Corp
  • Chrogene Aarogyam Biotech Pvt Ltd
  • Chronus Health Inc
  • City, University of London
  • Co-Diagnostics Inc
  • Cornell University
  • Curetis GmbH
  • Duke University
  • Edan Instruments Inc
  • EKF Diagnostics Holdings Plc
  • Electrocyt, Inc.
  • Emergent Detection Inc (Inactive)
  • Endeavor Sciences Inc
  • Entegrion Inc
  • ExcitePCR Corp
  • Fable Biyoteknoloji San ve Tic AS
  • Fawkes Biotechnology LLC
  • First Light Diagnostics Inc
  • Florida International University
  • Future Diagnostics Solutions BV
  • General Fluidics Corp
  • Giner Inc
  • GlucoSentient Inc
  • Glyconics Ltd
  • Haemokinesis Pty Ltd
  • HemoPalm Corp
  • IdbyDNA Inc
  • Indian Institute of Science
  • Intelligent Optical Systems, Inc.
  • Invivomon Inc (Inactive)
  • I-Sens Inc
  • LabNow Inc (Inactive)
  • LightDeck Diagnostics Inc
  • Louisiana State University
  • Lucendi Inc
  • Masaryk University
  • Maxygen-mobile DNA tests
  • McKesson Corp
  • Memorial Sloan Kettering Cancer Center
  • MobioSense Inc
  • MyMD Pharmaceuticals Inc
  • Nalia Systems Ltd
  • Nanomix Inc
  • NeuroCatch Inc
  • Newcastle University
  • Nikkiso Co Ltd
  • Nova Biomedical Corp
  • Novel Microdevices LLC
  • Ohmx Corp
  • OncoGenesis
  • Ontera Inc (Inactive)
  • Oregon State University
  • Pacific Nanoscience, Inc.
  • POC Medical Systems Inc
  • Prominex Inc
  • Qvella Corp
  • Radisens Diagnostics Ltd
  • Rapid Diagnostic Pvt Ltd
  • RMIT University
  • Samvardhana Motherson Health Solution Ltd
  • Scryb Inc
  • SeLux Diagnostics Inc
  • SenGenix Inc
  • SepTec
  • Smiths Detection Inc
  • StemTek Therapeutics SL
  • Sugentech Inc
  • Thermal Gradient Inc
  • ThreeFold Sensors (Inactive)
  • Trinity Biotech Plc
  • University of Calgary
  • University of California Berkeley
  • University of Glasgow
  • University of Illinois at Urbana-Champaign
  • University of Pittsburgh
  • Ural Federal University
  • ViroGates AS
  • Wellstat Diagnostics LLC